Nishla Keiser Ph.D.
Student Associate
Nishla Keiser focuses on providing analysis for due diligence, freedom-to-operate, and patentability opinions in the biotechnology and pharmaceutical areas. Her practice also includes preparing and prosecuting patent applications.
Before joining Finnegan, Dr. Keiser was a senior member at Global Prior Art, Inc., an intellectual property consulting firm. As division leader for the Biotechnology and Pharmaceuticals Group, her work included patent and scientific literature searching for prior art, validity, freedom-to-operate and IP landscape projects. Dr. Keiser’s project topics included biologic and small molecule therapeutics, drug delivery, diagnostics, and sequencing technologies.
Dr. Keiser received her Ph.D. from the Massachusetts Institute of Technology’s Biological Engineering Division, where she was supported by a National Science Foundation graduate fellowship. Her work focused on developing analytical techniques to study the biological roles of complex carbohydrates such as heparan sulfate and N-linked glycans. As an undergraduate, Dr. Keiser worked on research topics including controlled-release drug delivery microchips and genetic regulation of hormones and hormone receptors.
専門分野での活動
- American Bar Association (student member)
- Boston Patent Law Association
主な出版物
-
-
Coauthor. “Cell Surface Glypicans Are Low-Affinity Endostatin Receptors,” Molecular Cell, 7:811-822, 2001.
- Keiser N, et al. “Direct isolation and sequencing of specific protein-binding glycosaminoglycans,” Nature Medicine, 7:123-128, 2001.